Community/Retail

Findings highlight the need for health care providers to continue to educate patients on the risk of scurvy, ensuring proper vitamin C intake.

Pharmacists are encouraged to leverage prescription drug monitoring programs connect patients to community-based resources to address the opioid crisis and pharmacy deserts.

Had the pharmacy established safe opioid prescribing policies?

With the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.

Treatment with valacyclovir for a year decreased the risk of new or worsening eye disease by 26%.

The FDA announces a Class II recall for the lot #220128, which were reported to contain the presence of nitrosamine.

Researchers discuss how interleukin-5 monoclonal antibodies are a promising approach for patients who have steroid-resistant asthma.

The CDC Advisory Committee on Immunization Practice voted to expand the recommendation, which includes Prevnar 20 and Capvaxive.

Effectively educating patients about their medications and disease trajectory can improve adherence and outcomes.

The approval marks Abrysvo as the first and only RSV vaccine designated for adults younger than 50 that are at increased risk for LRTD.

Benefits include reducing serious health consequences, such as hospitalization and death, as well as the economic burden on health systems due to influenza infection.

Pharmacists can educate patients about how to recognize unsafe online sources of medications and ensure patients are properly educate on how to administer their medications.

Pharmacists will likely be the first contact for many affected patients, and they should be able to provide evidence-based advice on how to manage their infection.

Cabotegravir long-acting when used for HIV pre-exposure prophylaxis (PrEP) showed adherence, effectiveness, and improvements in quality of life by those who received the injection.

Despite suggestions to the contrary in previously conducted small clinical trials, montelukast did not provide benefit in patients with COVID-19 symptoms.

New recommendations from the American Stroke Association (ASA) emphasize the importance of healthy lifestyle habits and addressing health equity to reduce stroke risk.

The FDA previously accepted the biologic license application for CT-P13 as a subcutaneous formulation.

Pharmacists are positioned to combat the opioid crisis through educating the public and advocating for policy changes to enable harm reduction strategies.

Women are more likely to face burnout because they are often balancing both workload and family or home life responsibilities.

New ACIP recommendations provide clarity, but questions linger for those aged 60 to 74 years.

Data presented at IDWeek also showed greater disease-prevention effects in the community with PCV21 compared with prior pneumococcal vaccines.

The implementation of accountable care organizations (ACOs) also worsened disparities in any emergency department or hospital use for Medicaid-insured children with asthma.

When helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.

On the heels of Women Pharmacist Day on October 12, we highlight 3 female pharmacists who have followed unique career paths that help to drive innovation and change in the industry, beyond the retail pharmacy setting.

Digital eye strain is a common cause of dry, red, and itchy eyes.

A dedicated community pharmacist for over 40 years, Kessler has witnessed immense change and innovation throughout his career.

The connection of F proteins could help destabilize the virus prior to infection of the next host.